Publications (150,545)

Search

Assessment of side effects (SEs) impacting quality of life (QoL) in patients (pts) undergoing treatment (tx) for advanced breast cancer (ABC) in clinical practice: A real-world (RW) multi-country survey

Cardoso F, Rihani J, Aubel D, De Courcy J, Harmer V, Harbeck N, Casas A, et al. (2022)

Conference contribution

Irradiation of the locoregional Lymphatic Drainage Pathways of Breast Cancer: Is the prescribed Dose actually applied? A Planning Study by the DEGRO Breast Cancer Working Group

Duma MN, Piroth M, Fastner G, Baumann R, Combs S, Dunst J, Feyer P, et al. (2022)

Conference contribution

Total Neoadjuvant Therapy as Organ Preserving Therapy for Rectal Cancer: The CAO/ARO/AIO-16 Phase II Study

Gani C, Polat B, Ott O, Germer E, Koenigsrainer A, Kirschniak A, Clasen S, et al. (2022)

Conference contribution

Ultrasound-detected inflammation is more common in clinically manifest hand osteoarthritis than in painless bony enlarged finger joints: subanalysis of the population-based Bruneck study

Gasperi N, Schreiber N, Bosch P, Adinolfi A, Kleyer A, Hagen M, Gasperi C, et al. (2022)

Journal article

Patient-reported outcomes (PROs) from DESTINY-Breast03, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (MBC)

Curigliano G, Dunton K, Rosenlund M, Janek M, Cathcart J, Liu Y, Fasching P, Iwata H (2022)

Conference contribution

Cost effectiveness of pembrolizumab in combination with chemotherapy as neoadjuvant therapy and continued as a single agent as adjuvant therapy for high-risk early-stage TNBC in the United States

Fasching P, Huang M, Haiderali A, Xue W, Pan W, Zhou ZY, Hu P, et al. (2022)

Conference contribution

Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic TNBC that expresses PD-L1

Fasching P, Huang M, Haiderali A, Pan W, Hu P, Chaudhuri M, De Tilleghem CLB, et al. (2022)

Conference contribution

Implementation of Stereotactic Irradiation of Prostate Cancer using conventional Linear Accelerators: in the Direction of hypofractionated Dose Escalation

Serpa M, Spohn SKB, Wiehle R, Thomann B, Kuechler S, Rothe T, Gainey M, et al. (2022)

Conference contribution

Investigation of daily Activity, Sleep and neurocognitive Function in Glioblastoma Patients using TTFields Therapy in Routine clinical Care in Germany - the TIGER PRO-Active Study

Glas M, Tabatabai G, Fietkau R, Goldbrunner R, Baehr O (2022)

Conference contribution

Immunophanotype modulating Properties of Ferrous Clathrochelates and Irradiation in Lung Cancer Cells

Alomo J, Becker I, Roessel T, Denzler M, Heim L, Mokhir A, Klemt I, et al. (2022)

Conference contribution

‹ 1 ... 2,285 2,286 2,287 2,288 2,289 ... 15,055 ›